SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank100
3Y CAGR+85.8%
5Y CAGR+24.9%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+85.8%/yr
Annual compound
5Y CAGR
+24.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.46 | +217.3% |
| 2024 | 2.98 | -45.3% |
| 2023 | 5.45 | +269.6% |
| 2022 | 1.47 | -22.3% |
| 2021 | 1.90 | -39.1% |
| 2020 | 3.11 | +54.9% |
| 2019 | 2.01 | - |